Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Davignon

Showing results (21-30 of 236) with videos related to

Pageof 24
Sort By:
Annales D'Endocrinologie|March 10, 2001
[Mechanisms of action of statins and their pleiotropic effects]J Davignon, L Mabile
Transactions of the American Neurological Association|January 1, 1979
Biochemical changes in Friedreich's ataxiaA Barbeau, J Davignon
L'Union Medicale Du Canada|February 25, 1988
[Phenotype of apolipoprotein E, hyperlipidemia and atherosclerosis]J Davignon, G Roederer
L'Union Medicale Du Canada|March 1, 1978
[Plasma apolipoproteins in dyslipoproteinemias. III. Classical hyperlipemias]P Duclos, J Davignon
The American Journal of Cardiology|September 30, 1993
Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a "founder effect"J Davignon, M Roy
Endocrinology and Metabolism Clinics of North America|October 24, 1998
Genetics of lipoprotein disordersJ Davignon, J Genest
The Canadian Journal of Cardiology|June 17, 1998
Beyond LDL-cholesterol: can further reductions in CAD risk be achieved by considering triglycerides?J Davignon, T A Pearson
American Journal of Human Genetics|March 1, 1985
Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variationC F Sing, J Davignon
Cardiology Clinics|February 1, 1986
Risks for hyperlipidemiaA C Nestruck, J Davignon
Atherosclerosis|July 1, 1996
Triglycerides: a risk factor for coronary heart diseaseJ Davignon, J S Cohn
Pageof 24

Showing results (21-30 of 236) with videos related to

Sort By:
Pageof 24
Annales D'Endocrinologie|March 10, 2001
[Mechanisms of action of statins and their pleiotropic effects]J Davignon, L Mabile
Transactions of the American Neurological Association|January 1, 1979
Biochemical changes in Friedreich's ataxiaA Barbeau, J Davignon
L'Union Medicale Du Canada|February 25, 1988
[Phenotype of apolipoprotein E, hyperlipidemia and atherosclerosis]J Davignon, G Roederer
L'Union Medicale Du Canada|March 1, 1978
[Plasma apolipoproteins in dyslipoproteinemias. III. Classical hyperlipemias]P Duclos, J Davignon
The American Journal of Cardiology|September 30, 1993
Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a "founder effect"J Davignon, M Roy
Endocrinology and Metabolism Clinics of North America|October 24, 1998
Genetics of lipoprotein disordersJ Davignon, J Genest
The Canadian Journal of Cardiology|June 17, 1998
Beyond LDL-cholesterol: can further reductions in CAD risk be achieved by considering triglycerides?J Davignon, T A Pearson
American Journal of Human Genetics|March 1, 1985
Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variationC F Sing, J Davignon
Cardiology Clinics|February 1, 1986
Risks for hyperlipidemiaA C Nestruck, J Davignon
Atherosclerosis|July 1, 1996
Triglycerides: a risk factor for coronary heart diseaseJ Davignon, J S Cohn
Pageof 24